Method of Fish Oil Administration on Patient Compliance

Status Completed

Clinical Trial Summary

Many patients complain of fishy breath, upset stomach, or heartburn when taking the recommended amount of fish oil. A common recommendation made by pharmacists is to freeze the fish oil capsules to help decrease adverse gastrointestinal effects. Compliance with over-the-counter (OTC) fish oil is a concern considering the high number of capsules taken daily. The hypothesis of this study is that taking fish oil with milk will help lead to better patient compliance with no difference in adverse effects versus other administration methods.

Clinical Trial Description

Fish oil has many proposed health benefits such as lowering triglycerides, decreasing inflammation, and reducing risk factors for cardiovascular disease. In order to take the recommended daily dose for hypertriglyceridemia using an OTC fish oil supplement, the daily recommended dose is at least 2 grams (2 capsules) three times a day. The American Heart Association recommends 2-4 grams of omega-3 fatty acid a day to aid in triglyceride reduction. Fish oil is known to cause GI-related adverse effects. Although reported to help, freezing fish oil capsules is inconvenient requiring access to a freezer three times a day. Currently there is a lack of literature to specify the best administration technique or patient compliance data for OTC fish oil supplements. The purpose of this study is to determine an ideal method of taking fish oil. This study will include up to 60 patients that are between the ages of 18-65 years who would be considered generally healthy. Patients will be recruited via e-mails sent to faculty and students of the School of Pharmacy, via flyers in Walgreen's stores, and through word of mouth. The patients will be randomly assigned to one of four treatment groups. Each treatment group will be given 180 capsules and instructed to take two capsules three times a day for thirty days with either food, no food, milk, or frozen. At the end of thirty days, the patient will return the bottle with any remaining pills to the investigator and take a survey. The investigators will assess compliance via pill count. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)

Related Conditions & MeSH terms

Adverse Effects

Clinical Trial Details

NCT number	NCT01471366
Study type	Interventional
Source	University of Mississippi, Oxford
Contact
Status	Completed
Phase	N/A
Start date	November 2011
Completion date	July 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01764126` - Pneumococcal Protein Vaccine Safety and Immunogenicity Trial	Phase 1
Completed	`NCT00696839` - Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects	N/A
Completed	`NCT00361062` - Aggressive Behavior Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) During the First Month of Treatment	N/A
Completed	`NCT00346944` - Health Effects From Removal of Amalgam Restorations in Patients With Symptoms Allegedly Related to Dental Amalgam	Phase 4
Recruiting	`NCT05486923` - Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Population
Completed	`NCT01834898` - Safety and Tolerability of Controlled-release Oxycodone on Postoperative Pain in Oncologic Head and Neck Surgery	N/A
Completed	`NCT01041352` - Laryngeal Mask or Endotracheal Tube for Back Surgery in the Prone Position	N/A
Recruiting	`NCT05090384` - Pediatric GVHD Low Risk Steroid Taper Trial	Phase 2
Completed	`NCT02927587` - Optimal TCI Regimen for Sedation of Elderly Undergoing Fiberoptic Bronchoscopy	N/A
Completed	`NCT02162147` - How Safe Are Our Pediatric Emergency Departments?	N/A
Completed	`NCT00773942` - Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries	N/A
Completed	`NCT06102577` - Systemic Adverse Effects After Osteopathic Treatment and Vitamin C	N/A
Completed	`NCT01060410` - Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment	N/A
Active, not recruiting	`NCT00445016` - Neurologic Complications in Peripheral Regional Anesthesia - An Evaluation Based on a Standardized Protocol	N/A
Active, not recruiting	`NCT02668016` - Self-Assessment Method for Statin Side-effects Or Nocebo	Phase 4
Completed	`NCT01533792` - Effect of Non-surgical Periodontal Treatment	Phase 2
Active, not recruiting	`NCT05032976` - Korea Comirnaty Post-marketing Surveillance
Recruiting	`NCT01650272` - Efficacy and Safety Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Androgenetic Alopecia	Phase 1/Phase 2
Completed	`NCT01116323` - Emergency Department Crowding in Relation to In-hospital Adverse Medical Events
Completed	`NCT02159911` - Oral Misoprostol for Cervical Priming Before Hysteroscopy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.